Jen Walsh

Dr. Jen Walsh

Centre for Sleep Science, University of Western Australia
+1

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in SLEEP
Verified
Journal Article
Open access
PEPeter R. Eastwood
Peter R. Eastwood
MBMaree Barnes
Maree Barnes
JWJen Walsh
Jen Walsh
KMKathleen J. Maddison
Kathleen J. Maddison
GHGeoffrey Hee
Geoffrey Hee
DHDavid R. Hillman
David R. Hillman
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.

1 July 2009 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
DHDavid R. Hillman
David R. Hillman
JWJen Walsh
Jen Walsh
KMKathleen J. Maddison
Kathleen J. Maddison
PPPeter R. Platt
Peter R. Platt
JKJason P. Kirkness
Jason P. Kirkness
PEPeter R. Eastwood
Peter R. Eastwood
Background: Upper airway collapsibility is known to increase under anesthesia. This study assessed how this increase in collapsibility evolves during slow Propofol induction and how it relates to anesthesia-induced changes in upper airway muscle activity and conscious state. Methods: Nine healthy volunteers were studied. Anesthesia was induced with Propofol in a step-wise manner (effect-site concentration steps of 0.5 microg x ml(-1) from 0 to 3 microg x ml(-1) and thereafter to 4 microg x ml(-1) and 6 microg x ml(-1) [target-controlled infusion]). Airway patency was maintained with continuous positive airway pressure. Pharyngeal collapsibility was assessed at each concentration by measuring critical pressure. Intramuscular genioglossus electromyogram and anesthetic depth (bispectral index score) were monitored throughout. Loss of consciousness was defined as failure to respond to loud verbal command. Results: Loss of consciousness occurred at varying Propofol effect-site concentrations between 1.5 and 4.0 microg x ml(-1). Initially genioglossus electromyographic activity was sustained with increases in Propofol concentration, increasing in some individuals. At or approaching loss of consciousness, it decreased, often abruptly, to minimal values with an accompanying increase in critical pressure. In most subjects, bispectral index score decreased alinearly with increasing Propofol concentration with greatest rate of change coinciding with loss of consciousness. Conclusions: Slow stepwise induction of Propofol anesthesia is associated with an alinear increase in upper airway collapsibility. Disproportionate decreases in genioglossus electromyogram activity and increases in pharyngeal critical closing pressure were observed proximate to loss of consciousness, suggesting that particular vulnerability exists after transition from conscious to unconscious sedation. Such changes may have parallels with upper airway behavior at sleep onset.

7 January 2005 in The Journal of Physiology
Verified
Journal Article
Closed access
DGDaniel J. Green
Daniel J. Green
WBWilliam Bilsborough
William Bilsborough
LNLouise H. Naylor
Louise H. Naylor
CRChris Reed
Chris Reed
JWJeremy Wright
Jeremy Wright
JWJen Walsh
Jen Walsh

19 January 2015 in Sleep and Biological Rhythms
Verified
Journal Article
Closed access
PDF file
JSJames A Slater
James A Slater
TBThalia Botsis
Thalia Botsis
JWJen Walsh
Jen Walsh
SKStuart King
Stuart King
LSLeon Straker
Leon Straker
PEPeter R Eastwood
Peter R Eastwood

4 September 2013 in Journal of Sleep Research
Verified
Journal Article
Open access
PDF file
EKEric J. Kezirian
Eric J. Kezirian
GGGeorge S. Goding
George S. Goding
AMAtul Malhotra
Atul Malhotra
FOFergal J. O'DOnoghue
Fergal J. O'DOnoghue
GZGary Zammit
Gary Zammit
MBMaree Barnes
Maree Barnes
Summary: Reduced upper airway muscle activity during sleep is a key contributor to obstructive sleep apnea pathogenesis. Hypoglossal nerve stimulation activates upper airway dilator muscles, including the genioglossus, and has the potential to reduce obstructive sleep apnea severity. The objective of this study was to examine the safety, feasibility and efficacy of a novel hypoglossal nerve stimulation system (HGNS®; Apnex Medical, St Paul, MN, USA) in treating obstructive sleep apnea at 12 months following implantation. Thirty‐one subjects (35% female, age 52.4 ± 9.4 years) with moderate to severe obstructive sleep apnea and unable to tolerate positive airway pressure underwent surgical implantation and activation of the hypoglossal nerve stimulation system in a prospective single‐arm interventional trial. Primary outcomes were changes in obstructive sleep apnea severity (apnea–hypopnea index, from in‐laboratory polysomnogram) and sleep‐related quality of life [Functional Outcomes of Sleep Questionnaire (FOSQ)]. Hypoglossal nerve stimulation was used on 86 ± 16% of nights for 5.4 ± 1.4 h per night. There was a significant improvement (P < 0.001) from baseline to 12 months in apnea–hypopnea index (45.4 ± 17.5 to 25.3 ± 20.6 events h−1) and Functional Outcomes of Sleep Questionnaire score (14.2 ± 2.0 to 17.0 ± 2.4), as well as other polysomnogram and symptom measures. Outcomes were stable compared with 6 months following implantation. Three serious device‐related adverse events occurred: an infection requiring device removal; and two stimulation lead cuff dislodgements requiring replacement. There were no significant adverse events with onset later than 6 months following implantation. Hypoglossal nerve stimulation demonstrated favourable safety, feasibility and efficacy.

15 January 2006 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
JAJulian J. Armstrong
Julian J. Armstrong
MLMatthew S. Leigh
Matthew S. Leigh
DSDavid Sampson
David Sampson
JWJen Walsh
Jen Walsh
DHDavid R. Hillman
David R. Hillman
PEPeter R. Eastwood
Peter R. Eastwood
Background: Measurements of upper airway size and shape are important in investigating the pathophysiology of obstructive sleep apnea (OSA) and in devising, applying, and determining the effectiveness of treatment modalities. We describe an endoscopic optical technique (anatomic optical coherence tomography, aOCT) that provides quantitative real-time imaging of the internal anatomy of the human upper airway. Methods: Validation studies were performed by comparing aOCT- and computed tomography (CT)–derived measurements of cross-sectional area (CSA) in (1) conduits in a wax phantom and (2) the velo-, oro-, and hypopharynx during wakefulness in five volunteers. aOCT scanning was performed during sleep in one subject with OSA. Results: a OCT generated images of pharyngeal shape and measurements of CSA and internal dimensions that were comparable to radiographic CT images. The mean difference between aOCT- and CT-derived measurements of CSA in (1) the wax phantom was 2.1 mm2 with limits of agreement (2 SD) from −13.2 to 17.4 mm2 and intraclass correlation coefficient of 0.99 (p < 0.001) and (2) the pharyngeal airway was 14.1 mm2 with limits of agreement from −43.7 to 57.8 mm2 and intraclass correlation coefficient of 0.89 (p < 0.001). aOCT generated quantitative images of changes in upper airway size and shape before, during, and after an apneic event in an individual with OSA. Conclusions: a OCT generates quantitative, real-time measurements of upper airway size and shape with minimal invasiveness, allowing study over lengthy periods during both sleep and wakefulness. These features should make it useful for study of upper airway behavior to investigate OSA pathophysiology and aid clinical management.